World's Best Scientists 2026 revealed!
Xueguang Zhang

Xueguang Zhang

D-Index & Metrics

Immunology

D-Index
63
Citations
13795
World Ranking
3031
National Ranking
28

Xueguang Zhang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Xueguang Zhang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 266 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Xueguang Zhang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Xueguang Zhang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Xueguang Zhang is a researcher affiliated with Soochow University in China, specializing primarily in the field of Engineering with a particular focus on Electrical and Electronic Engineering. Their body of work spans multiple subfields including Control and Systems Engineering, Energy Engineering and Power Technology, Immunology, and Molecular Biology. The research contributions of Xueguang Zhang encompass a diverse set of topics related to electrical power systems and biomedical applications.

The main topics in Xueguang Zhang's research include Microgrid Control and Optimization, Power Systems and Renewable Energy, Multilevel Inverters and Converters, Energy Load and Power Forecasting, Silicon Carbide Semiconductor Technologies, Smart Grid Energy Management, and Nanoplatforms for cancer theranostics.

Xueguang Zhang has published extensively in reputable venues. Among the frequent publication outlets are:

  • IEEE Transactions on Power Electronics
  • IEEE Transactions on Sustainable Energy
  • IEEE Transactions on Industrial Electronics
  • Cell Death and Disease
  • International Journal of Electrical Power & Energy Systems

The researcher's recent papers illustrate both the technical depth and interdisciplinary nature of the work:

  • "A Novel Shared Energy Storage Planning Method Considering the Correlation of Renewable Uncertainties on the Supply Side" (2022), IEEE Transactions on Sustainable Energy
  • "PCC Voltage Perturbation Path Analysis and Compensation for Grid-Connected Voltage-Source Converter Under Weak Grid" (2020), IEEE Transactions on Industrial Electronics
  • "A Symmetrical Control Method for Grid-Connected Converters to Suppress the Frequency Coupling Under Weak Grid Conditions" (2020), IEEE Transactions on Power Electronics
  • "B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer" (2020), Cell Death and Disease
  • "A Five-Level Space Vector Modulation Scheme for Parallel Operated Three-Level Inverters With Reduced Line Current Distortion" (2020), IEEE Transactions on Power Electronics

Collaboration is a notable aspect of Xueguang Zhang's scientific activity. Frequent coauthors include Dianguo Xu, Qian Wang, Gaolin Wang, Guangbo Zhang, and Weiwei Li. The frequency of these partnerships indicates ongoing teamwork on topics related to electrical power electronics and energy systems.

Overall, the research portfolio of Xueguang Zhang centers on the engineering challenges of power electronics and energy management systems, while also including interdisciplinary ventures into molecular biology and immunology-related applications. This multidisciplinary approach is reflected in the variety of publication venues and research topics addressed.

Best Publications

  • Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.

    Bin Shen;Jun Zhang;Hongya Wu;Jianying Wang

  • High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation

    Chuan-Yong Mu;Jian-An Huang;Ying Chen;Cheng Chen

  • Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance

    Changping Wu;Yibei Zhu;Jingting Jiang;Jiemin Zhao

  • Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells

    Zongning Miao;Jun Jin;Lei Chen;Jianzhong Zhu

  • TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.

    Xin Gao;Yibei Zhu;Yibei Zhu;Gang Li;Haitao Huang

  • Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines.

    Yongjing Chen;Qin Wang;Bimin Shi;Ping Xu

  • TOXICOLOGICAL CHARACTERISTICS OF NANOPARTICULATE ANATASE TITANIUM DIOXIDE IN MICE

    Yanmei Duan;Jie Liu;Linglan Ma;Na Li

  • Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells

    Xin Gao;Xuefeng Wang;Qianting Yang;Xin Zhao

  • B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.

    Tongguo Shi;Yanchao Ma;Lei Cao;Shenghua Zhan

  • Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.

    Guangbo Zhang;Jianquan Hou;Jinfang Shi;Gehua Yu

  • IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells

    Qianting Yang;Gang Li;Gang Li;Yibei Zhu;Yibei Zhu;Lin Liu

  • T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses

    Yibei Zhu;Songguang Ju;Elizabeth Chen;Shao Dai

  • A miR-570 binding site polymorphism in the B7 - H1 gene is associated with the risk of gastric adenocarcinoma

    Weipeng Wang;Fang Li;Yong Mao;Huan Zhou

  • Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis.

    Chang-Ping Wu;Jing-Ting Jiang;Min Tan;Yi-Bei Zhu

  • Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

    Jing Sun;Lu-jun Chen;Guang-bo Zhang;Jing-ting Jiang

  • MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer.

    Jianjie Zhu;Lanxin Chen;Lingting Zou;Panpan Yang

  • Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.

    Klein B;Zhang Xg;Jourdan M;Boiron Jm

  • B7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinoma

    Lu-jun Chen;Jing Sun;Hong-ya Wu;Shu-ming Zhou

  • Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop

    Zong-Jiang Gu;Valerie Costes;Zhao Yang Lu;Xue-Guang Zhang

  • Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients

    Jing-Ting Jiang;Yue-Ping Shen;Chang-Ping Wu;Yi-Bei Zhu

  • IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.

    M. Jourdan;Xue Guang Zhang;M. Portier;J.-M. Boiron

  • A frequent somatic mutation in CD274 3'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding

    Weipeng Wang;Jing Sun;Fang Li;Rui Li

Frequent Co-Authors

Binfeng Lu
Binfeng Lu University of Pittsburgh
Jingting Jiang
Jingting Jiang Soochow University
Régis Bataille
Régis Bataille University of Angers
David L. Kaplan
David L. Kaplan Tufts University
Qiang Lu
Qiang Lu Soochow University
Olivera J. Finn
Olivera J. Finn University of Pittsburgh
Zhenxin Wang
Zhenxin Wang Chinese Academy of Sciences
John Wijdenes
John Wijdenes Grenoble Alpes University
Mauno Vihinen
Mauno Vihinen Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, pursuing related online degrees can open diverse career opportunities. Many professionals transition into specialized healthcare roles that complement their immunology background. For example, accelerated nurse practitioner programs offer a fast-tracked path for registered nurses aiming to specialize, with top options available through accelerated rn to np programs.

Specializing further, acute care nurse practitioner programs (ACNP) are ideal for immunology specialists seeking advanced clinical roles in critical care settings. You can learn more about these pathways via acnp programs, which highlight necessary qualifications and certifications.

For beginners or those switching careers, online nurse programs tailored for non-nurses provide essential foundational knowledge to enter the healthcare field. A great example of this is found in online rn programs for non nurses in florida, which facilitate smooth entry into nursing degrees without prior nursing experience.

Considering financial prospects, understanding the dnp salary by specialty can help guide career decisions by highlighting states and specialties with higher earning potential for those pursuing a Doctor of Nursing Practice (DNP) degree.

Best Scientists Citing Xueguang Zhang

Trending Scientists

Recently Published Articles